Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud`s phenomenon and ischemia. It was developed by the pharmaceutical company Schering AG and is marketed by Bayer Schering Pharma AG in Europe and Actelion Pharmaceuticals in the USA. ==Clinical pharmacology== Iloprost is a synthetic analogue of prostacyclin.
Found on http://en.wikipedia.org/wiki/Iloprost
<chemical> A stable synthetic analog of epoprostenol but with a longer half-life than the parent compound. The drug has vasodilator and antiplatelet activities and improves the fibrinolytic activity in patients with atherosclerotic disease, thereby providing them with further antithrombotic protection. It is also used in the treatment of rayn
Found on http://www.mondofacto.com/facts/dictionary?iloprost
(i´lo-prost) a synthetic analogue of prostacyclin that is a systemic and pulmonary arterial dilator, used in the treatment of primary pulmonary hypertension; administered by inhalation.
Found on http://www.encyclo.co.uk/local/21001
A substance that is being studied in the prevention of lung cancer. It belongs to the family of drugs called prostaglandin analogs.
Found on http://www.cancer.gov/dictionary?expand=I
No exact match found